Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy

• Conditions: Cerebral Aneurysm; Anterior Communicating Artery Aneurysm; Intracranial Aneurysm; Aneurysm, Ruptured

• Registration Number: NCT02444832
• Lead Sponsor: Hospital Clinic of Barcelona

Brief Summary

Based on the anatomical features of the anterior Communicating artery complex, the investigators will analyze the outcome of the ACoA aneurysms treated by endovascular therapy.

The most common site of intracranial aneurysms is the anterior communicating artery (AcomA). AcomA aneurysms account for approximately one-fourth of all intracranial aneurysms.

Recent publications have addressed specifically the endovascular treatment of AcoA aneurysms. Furthermore, detailed anatomic characteristics and the effects of the multiple variations of the anterior communicating artery complex have scarcely been reported.

The hemodynamic factors play a fundamental role in the adequate treatment of aneurismal coiling.

The objective of our registry is to analyze the impact of morphological configuration of the anterior communicating artery complex and the results of coil embolization in AcoA aneurysms

Detailed Description

Not available

Study Timeline

• Status Verified: 2015-05
• Study Start: 2015-05
• Study First Submitted: 2015-05-12
• Study First Submitted QC: 2015-05-14
• Last Update Submitted: 2015-05-14
• Study First Posted: 2015-05-15
• Last Update Posted: 2015-05-15
• Primary Completion: 2017-06
• Study Completion: 2017-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patient with Anterior Communicating Artery Aneurysm treated with endovascular coiling.

Exclusion Criteria

• Patients without imaging follow up of at least 12 months after endovascular treatment.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effective Aneurysm Coiling (no residual cerebral aneurysm)	1 year

Secondary Outcome Measures

Name	Time	Method
All Cause Mortality	1 year
Neurological Outcome (classified with the Glasgow Outcome Scale, Rankin Scale)	1 year	All patients will be classified with the Glasgow Outcome Scale, Rankin Scale.
Procedural device-related serious adverse events	1 year

Trial Locations

Locations (1)

Hospital Clinic; 🇪🇸 Barcelona, Spain